MGS Mfg. Group purchases injection molding facility

Special to The Freeman

April 18, 2014

GERMANTOWN – MGS Mfg. Group announced it has acquired Hospira’s injection molding facility in Buffalo, N.Y.

The transaction is scheduled to close at the end of June this year. Financial terms were not disclosed.
The Buffalo plant employs 120 people and runs 40 injection molding machines, ranging from 100 ton to 400 ton, producing parts for Hospira’s pharmaceutical and device businesses, according to the announcement.

As part of the purchase agreement, no Hospira employees will lose their jobs.

“This represents a strategic move for both companies,” says Paul Manley, MGS chief operating officer and chief financial officer, in a statement. “MGS has made, and will continue to make, substantial investments in manufacturing technologies and capabilities to increase service to our health care industry customers. This opportunity with Hospira will benefit both of our organizations.”

MGS Mfg. Group is headquartered in Germantown and is a leading supplier to the global plastics industry of tight tolerance injection molded components, injection molds, specialty multishot equipment and automation systems.

“MGS’s expertise in cost-efficient custom manufacturing and molding of components and sub–assemblies better positions Hospira to meet customers' evolving needs for molded parts,” said Matthew Stober, senior vice president of operations for Hospira, in a statement. “MGS meets or exceeds the ISO and FDA guidelines for single-use disposable plastics manufacturing and will ensure supply continuity is maintained at all Hospira facilities.”